0001209191-23-058677.txt : 20231214 0001209191-23-058677.hdr.sgml : 20231214 20231214171007 ACCESSION NUMBER: 0001209191-23-058677 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231212 FILED AS OF DATE: 20231214 DATE AS OF CHANGE: 20231214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Diez-Canseco Russell CENTRAL INDEX KEY: 0001818591 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39411 FILM NUMBER: 231487900 MAIL ADDRESS: STREET 1: C/O VITAL FARMS, INC. STREET 2: 3601 SOUTH CONGRESS AVENUE, SUITE C100 CITY: AUSTIN STATE: TX ZIP: 78704 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vital Farms, Inc. CENTRAL INDEX KEY: 0001579733 STANDARD INDUSTRIAL CLASSIFICATION: FOOD & KINDRED PRODUCTS [2000] IRS NUMBER: 270496985 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3601 SOUTH CONGRESS AVENUE STREET 2: SUITE C100 CITY: AUSTIN STATE: TX ZIP: 78704 BUSINESS PHONE: (877) 455-3063 MAIL ADDRESS: STREET 1: 3601 SOUTH CONGRESS AVENUE STREET 2: SUITE C100 CITY: AUSTIN STATE: TX ZIP: 78704 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-12 0 0001579733 Vital Farms, Inc. VITL 0001818591 Diez-Canseco Russell C/O VITAL FARMS, INC. 3601 SOUTH CONGRESS AVENUE, SUITE C100 AUSTIN TX 78704 1 1 0 0 President and CEO 1 Common Stock 2023-12-12 4 M 0 778 3.2461 A 206003 D Common Stock 2023-12-12 4 M 0 26722 3.6748 A 232725 D Common Stock 2023-12-12 4 S 0 25651 15.12 D 207074 D Common Stock 2023-12-13 4 S 0 418 15.06 D 206656 D Employee Stock Option (right to buy) 3.2461 2023-12-12 4 M 0 778 0.00 D 2026-12-01 Common Stock 778 11407 D Employee Stock Option (right to buy) 3.6748 2023-12-12 4 M 0 26722 0.00 D 2028-05-22 Common Stock 26722 194678 D This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.02 to $15.38 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Fully vested. /s/ Jason Minio, Attorney-in-Fact 2023-12-14